1. Home
  2. NBIX vs BNT Comparison

NBIX vs BNT Comparison

Compare NBIX & BNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.72

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Brookfield Wealth Solutions Ltd.

BNT

Brookfield Wealth Solutions Ltd.

HOLD

Current Price

$43.26

Market Cap

12.4B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
BNT
Founded
1992
2020
Country
United States
Bermuda
Employees
N/A
4000
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
12.4B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
BNT
Price
$130.72
$43.26
Analyst Decision
Strong Buy
Analyst Count
22
0
Target Price
$180.91
N/A
AVG Volume (30 Days)
1.1M
23.0K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
0.63%
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
N/A
Revenue Next Year
$13.14
N/A
P/E Ratio
$27.48
$19.14
Revenue Growth
977.51
N/A
52 Week Low
$105.50
$40.06
52 Week High
$160.18
$74.16

Technical Indicators

Market Signals
Indicator
NBIX
BNT
Relative Strength Index (RSI) 51.13 43.76
Support Level $124.62 $42.64
Resistance Level $135.88 $47.58
Average True Range (ATR) 3.58 1.07
MACD -0.12 -0.18
Stochastic Oscillator 59.98 15.64

Price Performance

Historical Comparison
NBIX
BNT

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About BNT Brookfield Wealth Solutions Ltd.

Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. The Company's reporting segments are Annuities, P&C, Life Insurance and Corporate and Other. Majority revenue is generated from Annuities segment followed by P&C.

Share on Social Networks: